New paper out by myself, @LauraJDowney, @zaina_mahmoud94, & @JeanMcHale2. Setting out where we are with medical devices regulation in the UK, how we got here, & where we might be going.
Our next @CHLSPBIRMINGHAM event is a joint seminar with @bhamlaw - a Hybrid Seminar Wednesday 16th Oct- 13:00- on Zoom / in person . Delighted that @profmq will be presenting on "A Psychedelic Research Agenda for Europe? The Quest for Therapeutic and Legal Legitimacy.” 1/2
@PatentsInHumans Prof Aisling McMahon & Dr Opeyemi Kolawole article just out #MedicalLawReview on 'Biobank Donation in search of public benefits & Potential impact of IPRs over access to health technologies developed: A focus on bioethical implications' https://t.co/pmMbX9Lhq8
Really excited to see this published today in @MedLawInt - my latest article considering the construction of the best interests of women with a SMI in the obstetric context and the untapped potential of advance decisions.
MindMed becomes the fourth organisation to receive such FDA Breakthrough Therapy Designation for a psychedelic drug candidate.
Previously, MAPS, Compass Pathways and Usona Institute received the designation, for MDMA and psilocybin (x2), respectively.
FDA Hands MindMed's LSD Candidate Breakthrough Therapy Designation in Generalised Anxiety Disorder; Company Provides 12-Week Data and Fleshes Out Phase 3 Program Plans
Our coverage:
https://t.co/w3Nod0DcW7
The next @CHLSPBIRMINGHAM Zoom seminar will be held on Thursday 7th March at 13:00. @sabrinakgermain & Emily Allbon @CityLawSchool & Mara Malagodi @Warwick_Law are giving the paper “Reproductive Rights as Socio-Economic Rights in Nepal” All very welcome!
Colorado’s Draft Natural Medicine Rules: A High-Level Overview
The first draft rules for CO's regulated psychedelics market were revealed on Feb 16th.
The folks at Vicente LLP have parsed through the 39-page draft rules to provide a concise overview.
https://t.co/FFQ9GjgsXC
A brief thread about a new paper by me on neurotech & human rights. Right at the time when #Neuralink reports its first in-human brain-computer interface implant (which is btw not the first brain implant, but a new device implanted through a new method)../
https://t.co/ulPsKkJ5Lo
Bullseye Chart: The Psychedelic Drug Development Pipeline
@MichaelHaichin and @NoahJSmith98 have produced the latest iteration of our psychedelic drug dev. bullseye chart.
Access and download the full-size chart here:
https://t.co/iOMggjhgCw
Good news - today is NOT the last day to submit an abstract to this unmissable event! There's another couple of weeks to do so!
@ilagalasso@SErikainen@PickersgillM
This is probably the most useful piece of privacy law Scholarship I ever read. Recommended to junior (or perhaps senior) colleagues..
https://t.co/oOLJRHTlal